Last 12 months
Inside the activity.
0 purchase rows · 25 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 12 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 8 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2021 Filed Jun 11, 2021 20:21 UTC |
HILLEMAN JERYL LDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 1,499 | $0.00 Strike: $211.89 | $0.00 |
DisclosureSEC source: 0001645113-21-000076 · wf-form4_162344285531541.xml · derivative · entry 3 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 Underlying: Ordinary Shares · 1,499 shares Expires 2031-06-09 F3 · derivative.exercise_date: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:21 UTC |
HILLEMAN JERYL LDirector
|
Disposition to issuerOrdinary Shares | 1,270 | $210.01 | $266,712.70 |
DisclosureSEC source: 0001645113-21-000076 · wf-form4_162344285531541.xml · nonDerivative · entry 2 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,944 F2 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:21 UTC |
HILLEMAN JERYL LDirector
|
GrantRestricted Stock Units | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001645113-21-000076 · wf-form4_162344285531541.xml · nonDerivative · entry 1 HILLEMAN JERYL L · CIK 0001216628 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,214 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:19 UTC |
Hung DavidDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 1,499 | $0.00 Strike: $211.89 | $0.00 |
DisclosureSEC source: 0001645113-21-000075 · wf-form4_162344277249172.xml · derivative · entry 2 Hung David · CIK 0001310880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 Underlying: Ordinary Shares · 1,499 shares Expires 2031-06-09 F2 · derivative.exercise_date: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:19 UTC |
Hung DavidDirector
|
GrantRestricted Stock Units | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001645113-21-000075 · wf-form4_162344277249172.xml · nonDerivative · entry 1 Hung David · CIK 0001310880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,714 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:18 UTC |
LEUNG GABRIELDirector
|
GrantOptions to Buy Ordinary Shares · Derivative | 1,499 | $0.00 Strike: $211.89 | $0.00 |
DisclosureSEC source: 0001645113-21-000074 · wf-form4_162344271604748.xml · derivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,499 Underlying: Ordinary Shares · 1,499 shares Expires 2031-06-09 F2 · derivative.exercise_date: Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:18 UTC |
LEUNG GABRIELDirector
|
GrantRestricted Stock Units | 814 | $0.00 | $0.00 |
DisclosureSEC source: 0001645113-21-000074 · wf-form4_162344271604748.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,859 F1 · shares: These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:49 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 1,000 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001645113-21-000070 · wf-form4_162318536093579.xml · derivative · entry 3 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,345 Underlying: Ordinary Shares · 1,000 shares Expires 2028-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:49 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 1,000 | $204.55 | $204,550.00 |
DisclosureSEC source: 0001645113-21-000070 · wf-form4_162318536093579.xml · nonDerivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,045 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:49 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 1,000 | $31.45 | $31,450.00 |
DisclosureSEC source: 0001645113-21-000070 · wf-form4_162318536093579.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 1,833 | $0.00 Strike: $47.56 | $0.00 |
DisclosureSEC source: 0001645113-21-000069 · wf-form4_162223413522679.xml · derivative · entry 3 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,332 Underlying: Ordinary Shares · 1,833 shares Expires 2029-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 1,833 | $200.00 | $366,600.00 |
DisclosureSEC source: 0001645113-21-000069 · wf-form4_162223413522679.xml · nonDerivative · entry 2 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,054 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Read SEC document |
| May 27, 2021 Filed May 28, 2021 20:36 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,833 | $47.56 | $87,177.48 |
DisclosureSEC source: 0001645113-21-000069 · wf-form4_162223413522679.xml · nonDerivative · entry 1 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed May 14, 2021 20:07 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 1,943 | $180.48 | $350,672.64 |
DisclosureSEC source: 0001645113-21-000068 · wf-form4_162102283236308.xml · nonDerivative · entry 1 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,054 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Read SEC document |
| May 11, 2021 Filed May 12, 2021 20:15 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 2,262 | $180.12 | $407,426.92 |
DisclosureSEC source: 0001645113-21-000067 · wf-form4_162085051621853.xml · nonDerivative · entry 3 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,997 F2 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:13 UTC |
Weinberg UriChief Science Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 3,846 | $0.00 Strike: $47.56 | $0.00 |
DisclosureSEC source: 0001645113-21-000066 · wf-form4_162085040881642.xml · derivative · entry 4 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,845 Underlying: Ordinary Shares · 3,846 shares Expires 2029-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:13 UTC |
Weinberg UriChief Science Officer
|
SaleOrdinary Shares | 1,804 | $189.65 | $342,128.60 |
DisclosureSEC source: 0001645113-21-000066 · wf-form4_162085040881642.xml · nonDerivative · entry 3 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,667 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:13 UTC |
Weinberg UriChief Science Officer
|
SaleOrdinary Shares | 3,846 | $189.65 | $729,393.90 |
DisclosureSEC source: 0001645113-21-000066 · wf-form4_162085040881642.xml · nonDerivative · entry 2 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,471 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Weinberg. Read SEC document |
| May 10, 2021 Filed May 12, 2021 16:13 UTC |
Weinberg UriChief Science Officer
|
Exercise / conversionOrdinary Shares | 3,846 | $47.56 | $182,915.76 |
DisclosureSEC source: 0001645113-21-000066 · wf-form4_162085040881642.xml · nonDerivative · entry 1 Weinberg Uri · CIK 0001811030 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 1,833 | $0.00 Strike: $47.56 | $0.00 |
DisclosureSEC source: 0001645113-21-000067 · wf-form4_162085051621853.xml · derivative · entry 4 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,165 Underlying: Ordinary Shares · 1,833 shares Expires 2029-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC |
Benaim ElyChief Medical Officer
|
SaleOrdinary Shares | 1,833 | $189.65 | $347,628.45 |
DisclosureSEC source: 0001645113-21-000067 · wf-form4_162085051621853.xml · nonDerivative · entry 2 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,259 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim. Read SEC document |
| May 10, 2021 Filed May 12, 2021 20:15 UTC |
Benaim ElyChief Medical Officer
|
Exercise / conversionOrdinary Shares | 1,833 | $47.56 | $87,177.48 |
DisclosureSEC source: 0001645113-21-000067 · wf-form4_162085051621853.xml · nonDerivative · entry 1 Benaim Ely · CIK 0001632237 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:17 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 1,290 | $199.67 | $257,574.30 |
DisclosureSEC source: 0001645113-21-000065 · wf-form4_162033218703219.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,272 F1 · shares: Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Mr. Shah. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:15 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOptions to Buy Ordinary Shares · Derivative | 1,000 | $0.00 Strike: $31.45 | $0.00 |
DisclosureSEC source: 0001645113-21-000064 · wf-form4_162033208722403.xml · derivative · entry 3 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,345 Underlying: Ordinary Shares · 1,000 shares Expires 2028-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested as of the date hereof. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:15 UTC |
LEUNG GABRIELDirector
|
SaleOrdinary Shares | 1,000 | $199.67 | $199,670.00 |
DisclosureSEC source: 0001645113-21-000064 · wf-form4_162033208722403.xml · nonDerivative · entry 2 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,045 F1 · shares: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Leung. Read SEC document |
| May 05, 2021 Filed May 6, 2021 20:15 UTC |
LEUNG GABRIELDirector
|
Exercise / conversionOrdinary Shares | 1,000 | $31.45 | $31,450.00 |
DisclosureSEC source: 0001645113-21-000064 · wf-form4_162033208722403.xml · nonDerivative · entry 1 LEUNG GABRIEL · CIK 0001236183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 5, 2021 20:09 UTC |
Shah PriteshChief Commercial Officer
|
SaleOrdinary Shares | 1,043 | $200.86 | $209,492.81 |
DisclosureSEC source: 0001645113-21-000063 · wf-form4_162024533376835.xml · nonDerivative · entry 2 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,562 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:09 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 2,333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001645113-21-000063 · wf-form4_162024533376835.xml · derivative · entry 3 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.expiration_date: Fully vested as of the date hereof. Read SEC document |
| May 03, 2021 Filed May 5, 2021 20:09 UTC |
Shah PriteshChief Commercial Officer
|
Exercise / conversionOrdinary Shares | 2,333 | $204.10 | $476,165.30 |
DisclosureSEC source: 0001645113-21-000063 · wf-form4_162024533376835.xml · nonDerivative · entry 1 Shah Pritesh · CIK 0001744884 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,605 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 600 | $216.69 | $130,016.40 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 22 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,393 F22 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $216.57 to $216.79. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 500 | $214.67 | $107,332.50 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 21 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 555,993 F21 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 500 shares in multiple trades at prices ranging from $213.99 to $214.91. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,500 | $213.35 | $320,020.50 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 20 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 556,493 F20 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,500 shares in multiple trades at prices ranging from $212.95 to $213.72. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 600 | $211.28 | $126,765.60 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 19 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,993 F19 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 600 shares in multiple trades at prices ranging from $211.18 to $211.38. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 521 | $210.18 | $109,504.30 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 18 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 558,593 F18 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 521 shares in multiple trades at prices ranging from $209.81 to $210.66. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 2,200 | $209.34 | $460,554.60 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 17 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,114 F17 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,200 shares in multiple trades at prices ranging from $208.74 to $209.72. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 4,500 | $207.80 | $935,118.00 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 16 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,314 F16 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,500 shares in multiple trades at prices ranging from $207.20 to $208.20. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,284 | $206.35 | $264,955.97 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 15 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,814 F15 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,284 shares in multiple trades at prices ranging from $206.04 to $207.01. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,600 | $205.43 | $328,689.60 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 14 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 567,098 F14 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $205.00 to $205.76. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,972 | $204.28 | $402,834.24 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 13 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 568,698 F13 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,972 shares in multiple trades at prices ranging from $203.96 to $204.90. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 2,555 | $203.25 | $519,311.42 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 12 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 570,670 F12 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,555 shares in multiple trades at prices ranging from $202.90 to $203.77. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 4,388 | $202.16 | $887,069.30 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 11 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,225 F11 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,388 shares in multiple trades at prices ranging from $201.85 to $202.74. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 4,125 | $201.55 | $831,377.25 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 10 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 577,613 F10 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,125 shares in multiple trades at prices ranging from $200.85 to $201.84. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 4,338 | $199.71 | $866,354.99 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 9 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,738 F9 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 4,338 shares in multiple trades at prices ranging from $199.50 to $200.30. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 10,563 | $198.98 | $2,101,794.05 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 8 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586,076 F8 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 10,563 shares in multiple trades at prices ranging from $198.49 to $199.43. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 13,612 | $197.83 | $2,692,875.57 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 7 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 596,639 F7 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 13,612 shares in multiple trades at prices ranging from $197.39 to $198.29. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 24,338 | $197.00 | $4,794,659.01 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 6 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,251 F6 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 24,338 shares in multiple trades at prices ranging from $196.38 to $197.38. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 8,814 | $196.07 | $1,728,187.42 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 5 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 634,589 F5 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 8,814 shares in multiple trades at prices ranging from $195.38 to $196.36. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,600 | $194.94 | $311,904.00 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 4 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 643,403 F4 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,600 shares in multiple trades at prices ranging from $194.38 to $195.35. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 2,090 | $193.57 | $404,563.39 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 3 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 645,003 F3 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 2,090 shares in multiple trades at prices ranging from $193.15 to $194.06. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| April 13, 2021 Filed Apr 15, 2021 22:29 UTC |
DOYLE WILLIAM FDirector · Executive Chairman
|
SaleOrdinary Shares | 1,900 | $192.52 | $365,795.60 |
DisclosureSEC source: 0001645113-21-000056 · wf-form4_161852573844212.xml · nonDerivative · entry 2 DOYLE WILLIAM F · CIK 0001194459 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647,093 F2 · price: On April 13, 2021, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 1,900 shares in multiple trades at prices ranging from $192.00 to $193.00. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.